|
A micropapillary pattern is predictive of a poor prognosis in lung adenocarcinoma, and reduced surfactant apoprotein A expression in the micropapillary pattern is an excellent indicator of a poor prognosis.
|
17431413
|
Mod. Pathol.
|
|
Aberrant expression of MUC4 in ovarian carcinoma: diagnostic significance alone and in combination with MUC1 and MUC16 (CA125).
|
16880776
|
Mod. Pathol.
|
|
Aberrant expression of mucin core proteins and o-linked glycans associated with progression of pancreatic cancer.
|
23446997
|
Clin. Cancer Res.
|
|
Aberrant expression of mucin core proteins and o-linked glycans associated with progression of pancreatic cancer.
|
23446997
|
Clin. Cancer Res.
|
|
Aberrant expression of transmembrane mucins, MUC1 and MUC4, in human prostate carcinomas.
|
16302265
|
Prostate
|
|
ADH-1 suppresses N-cadherin-dependent pancreatic cancer progression.
|
17721921
|
Int. J. Cancer
|
|
Biomarkers in Diagnosis of pancreatic carcinoma in fine-needle aspirates.
|
17019794
|
Am. J. Clin. Pathol.
|
|
Cancer metastasis facilitated by developmental pathways: Sonic hedgehog, Notch, and bone morphogenic proteins.
|
17914743
|
J. Cell. Biochem.
|
|
CCL21 induces extensive intratumoral immune cell infiltration and specific anti-tumor cellular immunity.
|
17273764
|
Int. J. Oncol.
|
|
Cell surface-associated mucins in signal transduction.
|
16904320
|
Trends Cell Biol.
|
|
Cellular features of senescence during the evolution of human and murine ductal pancreatic cancer.
|
21860420
|
Oncogene
|
|
Characterization of human mucin MUC17. Complete coding sequence and organization.
|
16737958
|
J. Biol. Chem.
|
|
Chemoenzymatically synthesized multimeric Tn/STn MUC1 glycopeptides elicit cancer-specific anti-MUC1 antibody responses and override tolerance.
|
16207894
|
Glycobiology
|
|
Chronic pancreatic inflammation induced by environmental tobacco smoke inhalation in rats.
|
16405548
|
Am. J. Gastroenterol.
|
|
Class III beta-tubulin, a marker of resistance to paclitaxel, is overexpressed in pancreatic ductal adenocarcinoma and intraepithelial neoplasia.
|
17714470
|
Histopathology
|
|
Clinical potential of mucins in diagnosis, prognosis, and therapy of ovarian cancer.
|
19012856
|
Lancet Oncol.
|
|
Complete suppression of tumor formation by high levels of basement membrane collagen.
|
18171981
|
Mol. Cancer Res.
|
|
Concise review: recent advances on the significance of stem cells in tissue regeneration and cancer therapies.
|
16794264
|
Stem Cells
|
|
Culture and immortalization of pancreatic ductal epithelial cells.
|
15542901
|
Methods Mol. Med.
|
|
Cyclin-dependent kinase 5 is amplified and overexpressed in pancreatic cancer and activated by mutant K-Ras.
|
21825040
|
Clin. Cancer Res.
|
|
Deregulation of MUC4 in gastric adenocarcinoma: potential pathobiological implication in poorly differentiated non-signet ring cell type gastric cancer.
|
18781152
|
Br. J. Cancer
|
|
Differential expression of metabolic genes in tumor and stromal components of primary and metastatic loci in pancreatic adenocarcinoma.
|
22412968
|
PLoS ONE
|
|
Dynamics of the immune reaction to pancreatic cancer from inception to invasion.
|
17909062
|
Cancer Res.
|
|
Early diagnosis of pancreatic cancer: neutrophil gelatinase-associated lipocalin as a marker of pancreatic intraepithelial neoplasia.
|
18392050
|
Br. J. Cancer
|
|
Emerging roles of MUC4 in cancer: a novel target for diagnosis and therapy.
|
17234748
|
Cancer Res.
|
|
Engineering antibodies for clinical applications.
|
17512622
|
Trends Biotechnol.
|
|
ErbB2 growth factor receptor, a marker for neuroendocrine cells?
|
15775699
|
Pancreatology
|
|
Evaluation of MUC6 mucin tandem repeats.
|
15716126
|
Biochim. Biophys. Acta
|
|
Expression of core 3 synthase in human pancreatic cancer cells suppresses tumor growth and metastasis.
|
23754791
|
Int. J. Cancer
|
|
Functions of tumorigenic and migrating cancer progenitor cells in cancer progression and metastasis and their therapeutic implications.
|
17273942
|
Cancer Metastasis Rev.
|
|
Generation and characterization of anti-MUC4 monoclonal antibodies reactive with normal and cancer cells in humans.
|
14729877
|
J. Histochem. Cytochem.
|
|
Hedgehog inhibition prolongs survival in a genetically engineered mouse model of pancreatic cancer.
|
18515410
|
Gut
|
|
Human MUC4 mucin induces ultra-structural changes and tumorigenicity in pancreatic cancer cells.
|
17595659
|
Br. J. Cancer
|
|
Human RNA polymerase II-associated factor complex: dysregulation in cancer.
|
17599057
|
Oncogene
|
|
Inhibition of MUC4 expression suppresses pancreatic tumor cell growth and metastasis.
|
14744777
|
Cancer Res.
|
|
Interactions between MUC1 and p120 catenin regulate dynamic features of cell adhesion, motility, and metastasis.
|
24371222
|
Cancer Res.
|
|
Interplay of distinct growth factors during epithelial mesenchymal transition of cancer progenitor cells and molecular targeting as novel cancer therapies.
|
17355951
|
Ann. Oncol.
|
|
K-Ras promotes growth transformation and invasion of immortalized human pancreatic cells by Raf and phosphatidylinositol 3-kinase signaling.
|
17332339
|
Cancer Res.
|
|
Kras(G12D) and Smad4/Dpc4 haploinsufficiency cooperate to induce mucinous cystic neoplasms and invasive adenocarcinoma of the pancreas.
|
17349581
|
Cancer Cell
|
|
Loss of fibulin-2 expression is associated with breast cancer progression.
|
17456760
|
Am. J. Pathol.
|
|
MicroRNA-200c modulates the expression of MUC4 and MUC16 by directly targeting their coding sequences in human pancreatic cancer.
|
24204560
|
PLoS ONE
|
|
Modelling oncogenic Ras/Raf signalling in the mouse.
|
19201597
|
Curr. Opin. Genet. Dev.
|
|
MUC1 is a counter-receptor for myelin-associated glycoprotein (Siglec-4a) and their interaction contributes to adhesion in pancreatic cancer perineural invasion.
|
17974963
|
Cancer Res.
|
|
MUC1 mucin stabilizes and activates hypoxia-inducible factor 1 alpha to regulate metabolism in pancreatic cancer.
|
22869720
|
Proc. Natl. Acad. Sci. U.S.A.
|
|
MUC1 regulates expression of multiple microRNAs involved in pancreatic tumor progression, including the miR-200c/141 cluster.
|
24143167
|
PLoS ONE
|
|
MUC4 and MUC5AC are highly specific tumour-associated mucins in biliary tract cancer.
|
18475301
|
Br. J. Cancer
|
|
MUC4 expression correlates with poor prognosis in small-sized lung adenocarcinoma.
|
17126950
|
Lung Cancer
|
|
MUC4 expression is a novel prognostic factor in patients with invasive ductal carcinoma of the pancreas.
|
16049287
|
J. Clin. Pathol.
|
|
MUC4 expression is regulated by cystic fibrosis transmembrane conductance regulator in pancreatic adenocarcinoma cells via transcriptional and post-translational mechanisms.
|
16799633
|
Oncogene
|
|
MUC4 is a novel prognostic factor of extrahepatic bile duct carcinoma.
|
16857800
|
Clin. Cancer Res.
|
|
MUC4 mucin interacts with and stabilizes the HER2 oncoprotein in human pancreatic cancer cells.
|
18381409
|
Cancer Res.
|
|
MUC4 mucin potentiates pancreatic tumor cell proliferation, survival, and invasive properties and interferes with its interaction to extracellular matrix proteins.
|
17406026
|
Mol. Cancer Res.
|
|
MUC4, a multifunctional transmembrane glycoprotein, induces oncogenic transformation of NIH3T3 mouse fibroblast cells.
|
19010895
|
Cancer Res.
|
|
MUC4-expressing pancreatic adenocarcinomas show elevated levels of both T1 and T2 cytokines: potential pathobiologic implications.
|
17032197
|
Am. J. Gastroenterol.
|
|
MUC4-mediated regulation of acute phase protein lipocalin 2 through HER2/AKT/NF-κB signaling in pancreatic cancer.
|
24240113
|
Clin. Cancer Res.
|
|
Mucin expression in pleomorphic adenoma of salivary gland: a potential role for MUC1 as a marker to predict recurrence.
|
15280401
|
J. Clin. Pathol.
|
|
Mucins in cancer: protection and control of the cell surface.
|
14681689
|
Nat. Rev. Cancer
|
|
Notch 2-positive progenitors with the intrinsic ability to give rise to pancreatic ductal cells.
|
15924149
|
Lab. Invest.
|
|
Oncogene-induced Nrf2 transcription promotes ROS detoxification and tumorigenesis.
|
21734707
|
Nature
|
|
Optimization of radioimmunotherapy of solid tumors: biological impediments and their modulation.
|
17309914
|
Clin. Cancer Res.
|
|
Overexpression of ecdysoneless in pancreatic cancer and its role in oncogenesis by regulating glycolysis.
|
22977192
|
Clin. Cancer Res.
|
|
Overexpression of GalNAc-transferase GalNAc-T3 promotes pancreatic cancer cell growth.
|
21625220
|
Oncogene
|
|
Palladin is overexpressed in the non-neoplastic stroma of infiltrating ductal adenocarcinomas of the pancreas, but is only rarely overexpressed in neoplastic cells.
|
17404500
|
Cancer Biol. Ther.
|
|
Pancreatic enzyme extract improves survival in murine pancreatic cancer.
|
15097858
|
Pancreas
|
|
Pathobiological implications of MUC16 expression in pancreatic cancer.
|
22066010
|
PLoS ONE
|
|
Pathology of genetically engineered mouse models of pancreatic exocrine cancer: consensus report and recommendations.
|
16397221
|
Cancer Res.
|
|
Phosphorylation of MUC1 by Met modulates interaction with p53 and MMP1 expression.
|
18625714
|
J. Biol. Chem.
|
|
Platelet-derived growth factor receptor beta-mediated phosphorylation of MUC1 enhances invasiveness in pancreatic adenocarcinoma cells.
|
17545600
|
Cancer Res.
|
|
Ras-driven transformation of human nestin-positive pancreatic epithelial cells.
|
18374182
|
Meth. Enzymol.
|
|
Recent advances in cancer stem/progenitor cell research: therapeutic implications for overcoming resistance to the most aggressive cancers.
|
17979879
|
J. Cell. Mol. Med.
|
|
Recent advances on multiple tumorigenic cascades involved in prostatic cancer progression and targeting therapies.
|
16195239
|
Carcinogenesis
|
|
Recent advances on the molecular mechanisms involved in pancreatic cancer progression and therapies.
|
16258363
|
Pancreas
|
|
Recent advances on the molecular mechanisms involved in the drug resistance of cancer cells and novel targeting therapies.
|
17786164
|
Clin. Pharmacol. Ther.
|
|
Recent progress on normal and malignant pancreatic stem/progenitor cell research: therapeutic implications for the treatment of type 1 or 2 diabetes mellitus and aggressive pancreatic cancer.
|
18791122
|
Gut
|
|
Recent progress on tissue-resident adult stem cell biology and their therapeutic implications.
|
18288619
|
Stem Cell Rev
|
|
Regulation of mucin expression: mechanistic aspects and implications for cancer and inflammatory diseases.
|
16487661
|
Biochim. Biophys. Acta
|
|
Relevance of MUC1 mucin variable number of tandem repeats polymorphism in H pylori adhesion to gastric epithelial cells.
|
18322957
|
World J. Gastroenterol.
|
|
Rosiglitazone and Gemcitabine in combination reduces immune suppression and modulates T cell populations in pancreatic cancer.
|
22864396
|
Cancer Immunol. Immunother.
|
|
Sonic hedgehog paracrine signaling regulates metastasis and lymphangiogenesis in pancreatic cancer.
|
19633682
|
Oncogene
|
|
Sonic hedgehog promotes desmoplasia in pancreatic cancer.
|
18829478
|
Clin. Cancer Res.
|
|
Stem cells: a revolution in therapeutics-recent advances in stem cell biology and their therapeutic applications in regenerative medicine and cancer therapies.
|
17671448
|
Clin. Pharmacol. Ther.
|
|
Structure, evolution, and biology of the MUC4 mucin.
|
18024835
|
FASEB J.
|
|
Targeting of cancer stem/progenitor cells plus stem cell-based therapies: the ultimate hope for treating and curing aggressive and recurrent cancers.
|
18427384
|
Panminerva Med
|
|
Targeting of cancer stem/progenitor cells plus stem cell-based therapies: the ultimate hope for treating and curing aggressive and recurrent cancers.
|
18427384
|
Panminerva Med
|
|
The human homologue of the RNA polymerase II-associated factor 1 (hPaf1), localized on the 19q13 amplicon, is associated with tumorigenesis.
|
16491129
|
Oncogene
|
|
The lectin domains of polypeptide GalNAc-transferases exhibit carbohydrate-binding specificity for GalNAc: lectin binding to GalNAc-glycopeptide substrates is required for high density GalNAc-O-glycosylation.
|
17215257
|
Glycobiology
|
|
The MUC gene family: their role in the diagnosis and prognosis of gastric cancer.
|
18830939
|
Histol. Histopathol.
|
|
The reactive tumor microenvironment: MUC1 signaling directly reprograms transcription of CTGF.
|
20697347
|
Oncogene
|
|
Transcriptional regulation of human mucin MUC4 by bile acids in oesophageal cancer cells is promoter-dependent and involves activation of the phosphatidylinositol 3-kinase signalling pathway.
|
14583090
|
Biochem. J.
|
|
Trp53R172H and KrasG12D cooperate to promote chromosomal instability and widely metastatic pancreatic ductal adenocarcinoma in mice.
|
15894267
|
Cancer Cell
|
|
Tumor suppression by collagen XV is independent of the restin domain.
|
22531369
|
Matrix Biol.
|
